Description
CAS Number:
863288-34-0
Overview
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting analog of growth hormone–releasing hormone (GHRH). The DAC modification extends its half-life, allowing sustained interaction with GHRH receptors and prolonged signaling activity in research models.
Mechanism of Action
- Activation of GHRH receptors (GHRH-R)
- Prolonged growth hormone signaling due to DAC binding
- Extended plasma stability and half-life
- Modulation of endocrine and pituitary signaling pathways
Research Applications
- Growth hormone pulsatility and signaling studies
- Endocrine system and pituitary research
- Long-acting peptide pharmacokinetics
- Hormonal regulation models
Key Characteristics
- Modified GHRH analog
- DAC (Drug Affinity Complex) for extended duration
- Long-acting peptide profile
- Studied in GH and endocrine pathways
For Research Purposes Only. Not for human consumption
Reviews
There are no reviews yet.